candesartan cilexetil and hydrochlorothiazide
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (candesartan cilexetil and hydrochlorothiazide) by ANI Pharmaceuticals is clinical pharmacology mechanism of action angiotensin ii is formed from angiotensin i in a reaction catalyzed by angiotensin-converting enzyme (ace, kininase ii). Approved for hypertension, to lower blood pressure, heart failure. First approved in 2015.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Mechanism of Action Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pressor agent of the renin -angiotensin system, with effects that include vasoconstriction, stimulation…
Worked on CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Thiazide Diuretic